Related Experiment Videos
Ultrasound-enhanced thrombolysis
1Vascular Medicine Unit, Department of Medicine, University of Rochester School of Medicine and Dentistry, Rochester, New York, USA. charles_francis@urmc.rochester.edu
Echocardiography (Mount Kisco, N.Y.)
|April 27, 2001
Summary
Ultrasound enhances thrombolytic therapy by improving drug delivery and altering fibrin structure, leading to faster clot breakdown and reduced bleeding. This innovative approach shows promise for more effective clot dissolution treatments.
Area of Science:
- Biomedical Engineering
- Cardiovascular Research
- Medical Physics
Background:
- Current thrombolytic therapies face challenges including slow clot lysis and significant bleeding risks.
- Ultrasound emerges as a promising adjunct to enhance thrombolytic treatments, potentially mitigating these issues.
Purpose of the Study:
- To evaluate the efficacy of ultrasound as an adjunct to thrombolytic therapy.
- To explore the mechanisms by which ultrasound improves thrombolysis and reduces bleeding complications.
Main Methods:
- In vitro studies demonstrating ultrasound's effects on fibrinolysis and drug transport.
- Animal models assessing ultrasound-accelerated thrombolysis in venous, arterial, and small vessel thrombosis.
- Investigation of high-intensity ultrasound for mechanical thrombus fragmentation and low-frequency ultrasound for enhanced tissue penetration.
Main Results:
- Low-intensity ultrasound improves enzymatic fibrinolysis by enhancing drug transport and fibrin structure.
- Ultrasound, delivered transcutaneously or endovascularly, accelerates thrombolysis in various thrombosis models.
- Higher intensity ultrasound can fragment thrombus mechanically, while lower frequencies (20-40 kHz) improve efficacy and penetration.
Conclusions:
- Ultrasound offers a significant potential to improve the effectiveness of thrombolytic therapy.
- Adjunctive ultrasound may decrease bleeding complications associated with clot dissolution treatments.
- Further clinical trials are warranted to validate ultrasound's role in optimizing thrombolytic strategies.